GLP-1s: The Honest Accounting
GLP-1s: The Honest Accounting
Diabetes: Beyond Metformin Part 2
Part 2 of the SGLT2 inhibitor breakdown. The emerging liver fat evidence. The safety profile of Jardiance, Farxiga, and Invokana. And the single most important medication-coaching conversation in the entire drug series for patients combining these drugs with low-carbohydrate or ketogenic dietary approaches. Part 1 of this SGLT2 conversation covered the underrated cardiovascular and kidney…
Drugs and Diabetes: Beyond Metformin
Empagliflozin, dapagliflozin, canagliflozin — the diabetes drugs that quietly do more than metformin. The honest accounting of mechanism, cardiovascular protection, kidney benefits, and how to think about them within a coaching framework where lifestyle remains the primary intervention. If Post 1 made the case that metformin’s reputation has been mythologized in places, this post is…
Drugs and Type 2 Diabetes- Metformin
The most-prescribed diabetes drug in the world has been mythologized for two decades. The actual evidence base is weaker than your doctor probably knows. Here’s what metformin actually does — and what it doesn’t. Metformin is the most-prescribed first-line diabetes drug in the world. It’s been in clinical use for over 60 years. It’s cheap,…
The Cure…
Type 2 diabetes is curable in the majority of patients for whom the disease is less than six years old. This is no longer fringe science. It is published, replicated, mechanistically explained — and almost never discussed at your doctor’s appointment. If you’ve been told that type 2 diabetes is a chronic, progressive disease that…
Something went wrong. Please refresh the page and/or try again.
Follow My Health and Fitness Blog
Get new content delivered directly to your inbox.
One BadAss BITCH 